Current NDC auxiliary source row compounder:111

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70092-658
Product Ndc: 70092-658
Product Ndc Digits: 70092658
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: L.E.T. Solution 3 ml in 5 ml TS
Proprietary Name Suffix: [empty]
Nonproprietary Name: L.E.T. Solution 3 ml in 5 ml TS
Dosage Form Name: SOLUTION
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: QuVa Pharma, Inc.
Establishment Name: QuVa Pharma, Inc.
Establishment Fei: [empty]
Substance Name: LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
Active Ingredients Info: 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL
History Active Ingredients Raw: LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
History Active Ingredients Info Raw: 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 70092-658-44
Package Ndc: 70092-658-44
Package Ndc Digits: 7009265844
Package Ndc11: 70092065844
Package Description: 3 mL in 1 SYRINGE (70092-658-44)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:111
Source Row Number: 111
Source Row Hash: 395c62e19fb5d790dba38bf960667873a4865b38216509915da282597ef62526
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "70092-658",
    "DEASCHEDULE": "",
    "LABELERNAME": "QuVa Pharma, Inc.",
    "SUBSTANCENAME": "LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "70092-658-44",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "L.E.T. Solution 3 ml in 5 ml TS",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "L.E.T. Solution 3 ml in 5 ml TS",
    "PACKAGEDESCRIPTION": "3 mL in 1 SYRINGE (70092-658-44) ",
    "ACTIVEINGREDIENTSINFO": "120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:111
Source Row Number: 111
Status Scope: package
Lookup Ndc: 70092-658-44
Lookup Ndc Digits: 7009265844
Product Ndc: 70092-658
Product Ndc Digits: 70092658
Package Ndc: 70092-658-44
Package Ndc Digits: 7009265844
Package Ndc11: 70092065844
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 395c62e19fb5d790dba38bf960667873a4865b38216509915da282597ef62526
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51